Overview
- 2 FDA inspections are on record.
- 2 inspections produced a Form 483.
- The most recent recorded inspection date is 2026-02-20.
At a glance
Inspections
2
Form 483s
2
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 9 Feb 2026 – 20 Feb 2026 | Human Drugs | 483 | View 483 → |
| 3 Sep 2024 – 18 Sep 2024 | Human Drugs | WL | On file |
Observations on record
Form 483 observations cited at this site, most recent first.
20 Feb 2026
21 CFR 211.160(b)
Scientifically sound laboratory controls
Cited by Chad W Rice, Carl A Huffman
20 Feb 2026
21 CFR 211.192
Investigations of discrepancies, failures
Cited by Chad W Rice, Carl A Huffman
20 Feb 2026
21 CFR 211.42(c)(10)(iv)
Environmental Monitoring System
Cited by Chad W Rice, Carl A Huffman
Investigators
FDA investigators tied to this site in the record.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10)(iv) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Staska Pharmaceuticals, Inc.'s 2 Form 483s
Recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat